A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection

Clinical trial NCT05489289 · RECRUITING

Trial details

NCT number: NCT05489289
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2023-01-05
Primary completion: 2026-01-28
Enrollment: 570

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.